Literature DB >> 8694553

Biological characterization of laryngeal squamous-cell carcinoma.

R M Tomasino1, V Bazan, E Daniele, R Nuara, V Morello, V Tralongo, G Leto, A Russo.   

Abstract

The traditional prognostic factors, including stage of disease and tumour grade, have shown a limited prognostic significance and an inability to predict clinical response to specific treatment in patients with laryngeal squamous-cell carcinoma. More recent data suggest that cell kinetics indices, DNA-ploidy, lysosomal cysteine proteinase expression and genetic changes of both tumour suppressor genes and protooncogenes may be considered as reliable and reproducible indicators of biological aggressiveness in these patients. Moreover, the frequency of different genetic alterations suggests that several pathways are involved in the genesis of these neoplasias and, in particular, it is very probable that p-53 expression and PCNA indices (increased in normal mucosa and preinvasive lesions) may constitute more important biomarkers for the early steps of laryngeal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694553

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Survival after laryngectomy: a review of 133 patients with laryngeal carcinoma.

Authors:  Theodoros A Papadas; Evangelos C Alexopoulos; Antony Mallis; Eleni Jelastopulu; Nicholas S Mastronikolis; Panos Goumas
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-18       Impact factor: 2.503

2.  Association between MDM2 rs769412 and rs937283 polymorphisms with alcohol drinking and laryngeal carcinoma risk.

Authors:  Hongzeng Wang; Kunpeng Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

3.  Quantitative proteomics approach to screening of potential diagnostic and therapeutic targets for laryngeal carcinoma.

Authors:  Li Li; Zhenwei Zhang; Chengyu Wang; Lei Miao; Jianpeng Zhang; Jiasen Wang; Binghua Jiao; Shuwei Zhao
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.